Galderma Investigational Site 6066

Buxtehude 21614

1 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults — Recruiting now
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed